China-based CAR-T company Oricell raises $40M more as it looks to go publicnews2026-04-10T10:28:17+00:00April 10th, 2026|Endpoints News|
FDA plans another safety study of abortion drug after court ordernews2026-04-09T18:29:48+00:00April 9th, 2026|Endpoints News|
AbbVie suggests new interpretation of ‘patient’ is necessary in 340B lawsuitnews2026-04-09T18:18:32+00:00April 9th, 2026|Endpoints News|
Post-Hoc Live: Biopharma M&A is back, with Barclays’ Emily Fieldnews2026-04-09T18:12:49+00:00April 9th, 2026|Endpoints News|
FDA lifts MacroGenics hold; Oxford and Bristol Myers team upnews2026-04-09T15:10:37+00:00April 9th, 2026|Endpoints News|
Everyone has a mental health chatbot. Now what?news2026-04-09T14:31:51+00:00April 9th, 2026|Endpoints News|
Shionogi’s BARDA contract; Scinai finalizes CDMO unit setupnews2026-04-09T14:31:05+00:00April 9th, 2026|Endpoints News|
Roche dips into DACs with existing partner C4 Therapeutics for $20M upfrontnews2026-04-09T14:17:59+00:00April 9th, 2026|Endpoints News|
China-based AI biotech Ailux hires CSO, eyes clinic in 2027news2026-04-09T14:00:15+00:00April 9th, 2026|Endpoints News|
Pulmonary fibrosis biotech Avalyn Pharma files for IPOnews2026-04-09T01:20:45+00:00April 9th, 2026|Endpoints News|
